DiaGen AI  /  News

Announced milestones.

December 2023 to date. Full releases are available at diagen.ai/news and via EIN Presswire.

All press releases · updated daily

DiaGen AI announces Collaboration & Revenue Share Agreement with Hadassah Medical Organization & Ariel University

Read the release →

DiaGen AI Inc. Appoints Life Sciences and AI Expert Aditya Tallapragada to Advisory Board

Read the release →

DiaGen AI Publishes Study: Biomarker Integration & Biosensor Tech Enabling AI Driven Insights in Biological Aging

Read the release →

DiaGen AI Inc. and Metanova Labs Announce Joint Venture LOI to Develop Hit Picking Tool for Automating Drug Discovery

Read the release →

DiaGen Ai Inc. Chosen Again as a Top 100 Canadian Tech Company Exhibiting as Part of the All In AI Event in Montreal, QC

Read the release →

DiaGen Ai Inc. Announces JV with Contango Labs to Launch its First Decentralized Drug Discovery Miner on Bittensor $TAO

Read the release →

DiaGen Ai Inc Announces its Selection as Top 100 Canadian Tech Company as Part of Scale Ai’s Delegation at VivaTech 2025

Read the release →

DiaGen AI and Mila Announce Partnership to Scale Protein Design in Diagnostics and Drug Discovery

Read the release →

DiaGen Ai Inc. Announces Participation in Upcoming Investor and Artificial Intelligence Conferences

Read the release →

DiaGen Ai Inc. Announces Research Collaboration with the Structural Genomics Consortium at UNC Chapel Hill

Read the release →

DiaGen Ai Inc. Announces Letter of Intent to Merge With Issuer Linceis Capital Corp

Read the release →

DiaGen Ai Inc. Announces Partnership with Cambridge, UK Based The Vaccine Group LTD. to Co-Develop Novel Vaccines

Read the release →

DiaGen Ai Inc., Announces Unit Financing and Appointment of Davidson & Company, LLP as Independent Auditor

Read the release →

Proteic Biosciences Inc. Announces Name Change to DiaGen Ai Inc., the Appointment of a New CEO, New Website and Update

Read the release →

Tech-Bio Partnering: Tools and Deployment

For platform access, catalog partnering or co-development enquiries.

IR@diagen.ai